Efficacy and safety of modified electroconvulsive therapy for the refractory depression in older patients.


Journal

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists
ISSN: 1758-5872
Titre abrégé: Asia Pac Psychiatry
Pays: Australia
ID NLM: 101506757

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 26 12 2019
accepted: 21 07 2020
pubmed: 13 8 2020
medline: 13 8 2021
entrez: 13 8 2020
Statut: ppublish

Résumé

We explored the clinical efficacy and safety of modified electroconvulsive therapy (ECT) in the treatment of elderly patients with refractory depression. A total of 43 older patients with refractory depression were enrolled in our study from March 2014 to February 2015, with the average age of 65 ± 4.8 years old. Modified electroconvulsive therapy (ECT) was performed in these patients after physical examinations and anesthesia procedures. Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA) were used to assessing the efficacy of ECT, and Wechsler Memory Scale (WMS) and mini-mental state examination (MMSE) were used to evaluate the memory ability and cognitive function. The rate of efficacy was calculated as 67.44% after 4 weeks of ECT treatment. Our results showed that HAMA and HAMD scores after 2 weeks of ECT treatment were significantly lower than pretreatment, and the differences were more significant after 4 weeks of ECT treatment. Compared with pretreatment, the scores of memory quotient and immediate memory of WMS decreased significantly after 1 week of treatment. However, these events were not be presented with the progress of treatment, except for after 2 weeks of treatment. Our results demonstrated that compared with pretreatment, the scores of MMSE significantly increased after 4 weeks of treatment. ECT is an effective, well-tolerated, and safe method for the treatment of older patients with refractory depression. ECT can be recommended for the treatment of these patients after conducting effective risk control of comorbid somatic diseases.

Identifiants

pubmed: 32783403
doi: 10.1111/appy.12411
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12411

Informations de copyright

© 2020 John Wiley & Sons Australia, Ltd.

Références

D, W. (2002). WAIS-III/WMS-III technical manual (pp. 118-121). https://www.scienceopen.com/document?vid=2844e9e8-8d61-4621-8e8f-84b2255e4fb9.
GS, A. (2005). Depression in the elderly. Lancet, 365, 1961-1970.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62. https://doi.org/10.1136/jnnp.23.1.56
Stoppe, A., Louzã, M., Rosa, M., Gil, G., & Rigonatti, S. (2006). Fixed high-dose electroconvulsive therapy in the elderly with depression: A double-blind, randomized comparison of efficacy and tolerability between unilateral and bilateral electrode placement. The Journal of ECT, 22(2), 92-99. https://doi.org/10.1097/00124509-200606000-00003
van Schaik, A. M., Comijs, H. C., Sonnenberg, C. M., Beekman, A. T., Sienaert, P., & Stek, M. L. (2012). Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: A systematic review. The American Journal of Geriatric Psychiatry, 20(1), 5-17. https://doi.org/10.1097/JGP.0b013e31820dcbf9
Weng, W. (2002). Charge choice of first treatment with multi-functional ECT. Shanghai Archives of Psychiatry, (02). http://en.cnki.com.cn/Article_en/CJFDTOTAL-JSYI200202007.htm.
X, J. (2013). Advance in diagnosis and treatment of geriatric depression. Practical Geriatrics, 27(9), 774-776.
Zhao, L., Fan, Y., Dong, Y., & Meng, X. (2015). Modified electroconvulsive therapy in the elderly with depressive disorders. Acta Academiae Medicinae Qingdao Universitatis. http://en.cnki.com.cn/Article_en/CJFDTotal-BATE201501016.htm.
Zhou, P., Z, W., & Xie, Z. (2012). Advance in prevention and treatment of geriatric depression. Chinese Journal of Gerontology, 32, 4359-4361.

Auteurs

Xue Jiang (X)

Psychiatric Intensive Care Unit (PICU), Wuhan Mental Health Center, Wuhan, Hubei, China.

Qin Xie (Q)

Psychiatric Intensive Care Unit (PICU), Wuhan Mental Health Center, Wuhan, Hubei, China.

Lian-Zhong Liu (LZ)

Wuhan Mental Health Center, Wuhan, Hubei, China.

Bao-Liang Zhong (BL)

Wuhan Mental Health Center, Wuhan, Hubei, China.

Liang Si (L)

Psychiatric Intensive Care Unit (PICU), Wuhan Mental Health Center, Wuhan, Hubei, China.

Fang Fan (F)

Psychiatric Intensive Care Unit (PICU), Wuhan Mental Health Center, Wuhan, Hubei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH